Determination of the Acceptable Ambient Light Exposure during Drug Product Manufacturing for Long-Term Stability of Monoclonal Antibodies

Lin M. Luis; Yuzhe Hu; Camellia Zamiri; Alavattam Sreedhara

doi:10.5731/pdajpst.2018.008581

Research ArticleResearch

Determination of the Acceptable Ambient Light Exposure during Drug Product Manufacturing for Long-Term Stability of Monoclonal Antibodies

Lin M. Luis, Yuzhe Hu, Camellia Zamiri and Alavattam Sreedhara

PDA Journal of Pharmaceutical Science and Technology July 2018, 72 (4) 393-403; DOI: https://doi.org/10.5731/pdajpst.2018.008581

Lin M. Luis

Late Stage Pharmaceutical Development, Genentech Inc., a Member of the Roche Group, South San Francisco, CA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Yuzhe Hu

Late Stage Pharmaceutical Development, Genentech Inc., a Member of the Roche Group, South San Francisco, CA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Camellia Zamiri

Late Stage Pharmaceutical Development, Genentech Inc., a Member of the Roche Group, South San Francisco, CA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Alavattam Sreedhara

Late Stage Pharmaceutical Development, Genentech Inc., a Member of the Roche Group, South San Francisco, CA, USA

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: alavattam.sreedhara@gene.com

Article
Figures & Data
References
Info & Metrics
PDF

Article Information

vol. 72 no. 4 393-403

DOI

https://doi.org/10.5731/pdajpst.2018.008581

PubMed

29853610

Published By

Parenteral Drug Association (PDA)

Print ISSN

1079-7440

Online ISSN

1948-2124

History

Published online August 9, 2018.

Article Versions

previous version (May 31, 2018 - 12:56).
You are viewing the most recent version of this article.

Author Information

Lin M. Luis,
Yuzhe Hu,
Camellia Zamiri and
Alavattam Sreedhara*

Late Stage Pharmaceutical Development, Genentech Inc., a Member of the Roche Group, South San Francisco, CA, USA

↵* Corresponding Author: Late Stage Pharmaceutical Development, Genentech Inc., a Member of the Roche Group, 1 DNA Way, South San Francisco, CA 94080, USA. Telephone: 650-467-8488; e-mail: alavattam.sreedhara{at}gene.com

View Full Text

Cited By...

19 Citations
Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

Physicochemical Stability of Monoclonal Antibodies: A Review

Yoann Le Basle, Philip Chennell, Nicolas Tokhadze, Alain Astier, Valérie Sautou

Journal of Pharmaceutical Sciences 2020 109 1
Science and art of protein formulation development

Wei Wang, Satoshi Ohtake

International Journal of Pharmaceutics 2019 568
Photo-Degradation of Therapeutic Proteins: Mechanistic Aspects

Christian Schöneich

Pharmaceutical Research 2020 37 3
Near UV and Visible Light Induce Iron-Dependent Photodegradation Reactions in Pharmaceutical Buffers: Mechanistic and Product Studies

Natalia Subelzu, Christian Schöneich

Molecular Pharmaceutics 2020 17 11
Probing the Tryptophan Environment in Therapeutic Proteins: Implications for Higher Order Structure on Tryptophan Oxidation

Gregory V. Barnett, Gurusamy Balakrishnan, Naresh Chennamsetty, Laurel Hoffman, Jacob Bongers, Li Tao, Yunping Huang, Thomas Slaney, Tapan K. Das, Anthony Leone, Sambit R. Kar

Journal of Pharmaceutical Sciences 2019 108 6
Stress Factors in Protein Drug Product Manufacturing and Their Impact on Product Quality

Tapan K. Das, Alavattam Sreedhara, James D. Colandene, Danny K. Chou, Vasco Filipe, Christoph Grapentin, Jim Searles, Twinkle R. Christian, Linda O. Narhi, Wim Jiskoot

Journal of Pharmaceutical Sciences 2022 111 4
Light-Induced Histidine Adducts to an IgG1 Molecule Via Oxidized Histidine Residue and the Potential Impact of Polysorbate-20 Concentration

Ming Lei, Cynthia Quan, John. Y. Wang, Yung-Hsiang Kao, Christian Schöneich

Pharmaceutical Research 2021 38 3
Pharmaceutical Excipients Enhance Iron-Dependent Photo-Degradation in Pharmaceutical Buffers by near UV and Visible Light: Tyrosine Modification by Reactions of the Antioxidant Methionine in Citrate Buffer

Natalia Subelzu, Christian Schöneich

Pharmaceutical Research 2021 38 5
Roadmap for Drug Product Development and Manufacturing of Biologics

Krishnan Sampathkumar, Bruce A. Kerwin

Journal of Pharmaceutical Sciences 2024 113 2
Primary Processes of Free Radical Formation in Pharmaceutical Formulations of Therapeutic Proteins

Christian Schöneich

Biomolecules 2023 13 7
Effect of light source and UVA quotient on monoclonal antibody stability during ambient light exposure studies

Haresh T. More, Dilbir S. Bindra, Alexandra Zumba, Kaimeng Zhou, Thiago Carvalho, Rao Mantri

European Journal of Pharmaceutics and Biopharmaceutics 2023 185
Near UV Photodegradation Mechanisms of Amino Acid Excipients: Formation of the Carbon Dioxide Radical Anion from Aspartate and Fe(III)

Yilue Zhang, Yaqi Wu, Christian Schöneich

Molecular Pharmaceutics 2024 21 3
Stability of Protein Pharmaceuticals: Recent Advances

Mark Cornell Manning, Ryan E. Holcomb, Robert W. Payne, Joshua M. Stillahn, Brian D. Connolly, Derrick S. Katayama, Hongcheng Liu, James E. Matsuura, Brian M. Murphy, Charles S. Henry, Daan J. A. Crommelin

Pharmaceutical Research 2024 41 7
Physical Instabilities of Therapeutic Monoclonal Antibodies: A Critical Review

Arpit Arun K. Bana, Priti Mehta, Khushboo Ashok Kumar Ramnani

Current Drug Discovery Technologies 2022 19 6
Visible Light Degradation of a Monoclonal Antibody in a High-Concentration Formulation: Characterization of a Tryptophan-Derived Chromophoric Photo-product by Comparison to Photo-degradation of N-Acetyl-l-tryptophan Amide

Indira Prajapati, Nicholas R. Larson, Sureshkumar Choudhary, Cavan Kalonia, Suzanne Hudak, Reza Esfandiary, C. Russell Middaugh, Christian Schöneich

Molecular Pharmaceutics 2021 18 9
Protein photodegradation in the visible range? Insights into protein photooxidation with respect to protein concentration

Elena Hipper, Florian Lehmann, Wolfgang Kaiser, Göran Hübner, Julia Buske, Michaela Blech, Dariush Hinderberger, Patrick Garidel

International Journal of Pharmaceutics: X 2023 5
Near UV Light Photo-Degradation of Lactate and Related α-Hydroxycarboxylates in the Presence of Fe(III): Formation of Carbon Dioxide Radical Anion

Yilue Zhang, David S. Richards, Christian Schöneich

Journal of Pharmaceutical Sciences 2024 113 9
Near UV and Visible Light Photodegradation in Solid Formulations: Generation of Carbon Dioxide Radical Anions from Citrate Buffer and Fe(III)

Maribel Espinoza Ballesteros, Christian Schöneich

Molecular Pharmaceutics 2024 21 9
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

John Geigert

2019

PreviousNext

In This Issue

PDA Journal of Pharmaceutical Science and Technology

Vol. 72, Issue 4

July/August 2018

Table of Contents
Index by Author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Determination of the Acceptable Ambient Light Exposure during Drug Product Manufacturing for Long-Term Stability of Monoclonal Antibodies

Message Subject (Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology

Message Body (Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Math question * 2 + 6 =

Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

Citation Tools

Determination of the Acceptable Ambient Light Exposure during Drug Product Manufacturing for Long-Term Stability of Monoclonal Antibodies

Lin M. Luis, Yuzhe Hu, Camellia Zamiri, Alavattam Sreedhara

PDA Journal of Pharmaceutical Science and Technology Jul 2018, 72 (4) 393-403; DOI: 10.5731/pdajpst.2018.008581

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Determination of the Acceptable Ambient Light Exposure during Drug Product Manufacturing for Long-Term Stability of Monoclonal Antibodies

Lin M. Luis, Yuzhe Hu, Camellia Zamiri, Alavattam Sreedhara

PDA Journal of Pharmaceutical Science and Technology Jul 2018, 72 (4) 393-403; DOI: 10.5731/pdajpst.2018.008581

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Jump to section

Article
Figures & Data
References
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Main menu

User menu

Search

Determination of the Acceptable Ambient Light Exposure during Drug Product Manufacturing for Long-Term Stability of Monoclonal Antibodies

Article Information

Article Versions

Author Information

Cited By...

In This Issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.